3D Printing Unpeeled: Screen Printing Drugs, Repair Process for Marines & PCL Drug Release
Contract development and manufacturing organization (CDMO) Adare Pharma Solutions, is partnering with Laxxon Medical. The CDMO will use Screen-Printed Innovative Drug (SPID) to make oral dosage forms where they hope to do things with drug release, multiple APIs, make drugs that are easier to swallow and even help with taste masking. The company aims to buy two printers; one has been installed in Milan, and the other will be in Ohio.
The United States Marine Corps has worked with Naval Air Systems Command’s (NAVAIR) Additive Manufacturing (AM) Integrated Product Team (IPT) on a Suitable Substitute Engineering Change Proposal (ECP) for a 3D printed part replacing a conventional one. The part is a Bell UH-1Y rescue hoist chain guard cover. It is hoped that in future this process will be used to make more non critical parts faster. The part ordering process cost $1,700 whereas normally it would cost $300,000.
Researchers Zheru Ma, Yao Zhao, Zhe Xu and Yao Zhang from the Department of Bone and Joint Surgery, Orthopedic Center of the First Hospital of Jilin University, have published a paper on using PCL and antibiotics to make a controlled release solution that stops biofilm formation and allows for controlled antibiotic release on titanium implants.
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
You May Also Like
3D Printing Market Reaches $3.45B in Q2 2024, Marking 8.4% Year-Over-Year Growth
The global 3D printing market continued its upward trajectory in the second quarter of 2024, totaling $3.45 billion—a year-over-year increase of 8.4%. Despite a slight sequential decline from $3.47 billion...
Unlocking the Future of Investment Casting: 3D Systems’ Patrick Dunne on QuickCast Air
On the floor of this year’s International Manufacturing Technology Show (IMTS), the theme for original equipment manufacturers (OEMs) in additive manufacturing (AM) seemed to be indirect production. What if, by...
FDA Clears 3D Systems’ New Multi-Material Solution for 3D Printed Dentures
3D Systems (NYSE: DDD), the additive manufacturing (AM) industry pioneer based in South Carolina, has achieved Food and Drug Administration (FDA) clearance for its one-piece, multi-material denture printing solution. 3D...
3D Printing Targets Tooling at IMTS 2024
The Western hemisphere’s largest manufacturing trade show, the International Manufacturing Technology Show (IMTS), returned to Chicago for another year, graciously including a 3D printing section once again in its West...
